Skip to main content
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc. — Investor Relations & Filings

Ticker · TRVI ISIN · US89532M1018 US Manufacturing
Open in API
Filings indexed 505 across all filing types
Latest filing 2021-04-15 Director's Dealing
Country US United States of America
Listing US TRVI

About Trevi Therapeutics, Inc.

https://www.trevitherapeutics.com/

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of its investigational therapy, Haduvio™ (oral nalbuphine ER). The company's primary program is aimed at treating chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (non-IPF ILD), and refractory chronic cough (RCC). These conditions represent a significant unmet medical need with no approved therapies in the United States. Haduvio is a dual-mechanism therapy that acts as a kappa opioid receptor agonist and a mu opioid receptor antagonist, targeting both central and peripheral nerve pathways believed to cause chronic cough. The company has reported positive results from its Phase 2b CORAL trial in IPF chronic cough and its Phase 2a RIVER trial in refractory chronic cough.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-04-15 English
FORM 3 SUBMISSION
Director's Dealing
2021-04-15 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 29, 2021, by Trevi Therapeutics, Inc. The key content is about the departure of a principal accounting officer and the hiring of a new controller and principal accounting officer, including details about the new hire's background and compensation. This corresponds to an announcement of changes in the company's senior management. There are no financial statements or detailed financial data present, so it is not an Annual Report, Interim Report, or Earnings Release. The document fits the category of Board/Management Information (MANG) as it announces management changes.
2021-04-02 English
10-K
Annual Report FY 2020
2021-03-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 25, 2021, reporting the company's financial results for the quarter and year ended December 31, 2020. The text states that the full press release is furnished as an exhibit and incorporated by reference, and the document itself is a current report rather than the full earnings release. The document length is 3664 characters, which is relatively short and mainly serves as an announcement of the earnings results rather than containing detailed financial data. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) are classified as Earnings Release (ER). This document fits that description as it announces the financial results and includes a press release as an exhibit, but does not contain the full detailed financial statements itself.
2021-03-25 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated March 18, 2021. The content specifically announces the resignation of the Chief Financial Officer and the appointment of the President and CEO as the new principal financial officer. This is a clear announcement of changes in senior management. The document does not contain financial statements or detailed financial data, nor is it an earnings release or annual report. It is not a proxy statement or voting result announcement. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 4265 characters, which is consistent with a typical 8-K management change announcement. Confidence is high due to the explicit mention of director/officer departure and appointment.
2021-03-22 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.